Figure 3 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers gan Milana A. Bergamino (15038015)

Pynciau:

Figure 4 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers gan Milana A. Bergamino (15038015)

Pynciau:

Figure 2 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers gan Milana A. Bergamino (15038015)

Pynciau:

Figure 5 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers gan Milana A. Bergamino (15038015)

Pynciau:

Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers gan Milana A. Bergamino (15038015)

Pynciau:

Figure 6 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers gan Milana A. Bergamino (15038015)

Pynciau:

Figure S4 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy gan Alexander J. Cole (14971167)

Pynciau:

Figure S3 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy gan Alexander J. Cole (14971167)

Pynciau:

Figure S1 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy gan Alexander J. Cole (14971167)

Pynciau:

Figure S2 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy gan Alexander J. Cole (14971167)

Pynciau:

Figure S5 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy gan Alexander J. Cole (14971167)

Pynciau:

Supplementary Table S1 from Ablation of p57⁺ Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors gan Takeru Oka (15386810)

Pynciau:

Source Data from Ablation of p57⁺ Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors gan Takeru Oka (15386810)

Pynciau:

Supplementary File 2 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer gan Charles Blatti (15292859)

Pynciau:

Supplementary File 3 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer gan Charles Blatti (15292859)

Pynciau:

Supplementary File 4 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer gan Charles Blatti (15292859)

Pynciau: